| Ticker | BHVN |
|---|---|
| ISIN | VGG1110E1079 |
| Sector | Atención sanitaria |
| Mercado | NYSE |
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
El precio actual de Biohaven Ltd. (BHVN) es de 9,88 , con una variación del -6,13%.
Biohaven Ltd. opera en el sector Healthcare, industria Biotechnology.